On June 13th, imeik technology development stated on the interactive platform that product overseas expansion is a systematic work that requires product registration, filing and relevant work before expanding overseas. The company's injection A-type botulinum toxin is currently in the process of registration and declaration, and the specific time for the product to go on the market needs to wait for the review results of the National Medical Products Administration.
爱美客：注射用A型肉毒毒素正在整理注册申报阶段
imeik technology development: Type A botulinum toxin for injection is currently in the process of organizing registration and application.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.